-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Versigent, Lowers Price Target to $52

Benzinga·11/05/2026 20:07:37
Listen to the news
RBC Capital analyst Tom Narayan maintains Versigent (NYSE:VGNT) with a Outperform and lowers the price target from $53 to $52.